Diosgenin stimulates osteogenic activity by increasing bone matrix protein synthesis and bone-specific transcription factor Runx2 in osteoblastic MC3T3-E1 cells

Journal of Nutritional Biochemistry

Volumn 22, Issue 11, 2011, Pages 1055-1063

  Alcantara, Ethel H ^a   Shin, Mee Young ^a   Sohn, Ho Yong ^a   Park, Youn Moon ^a   Kim, Taewan ^a   Lim, Jae Hwan ^a   Jeong, Hyung Jin ^a   Kwon, Soon Tae ^a   Kwun, In Sook ^a  

^a Andong National University   (South Korea)

Author keywords

ALP activity; Diosgenin; MC3T3 E1 cells; Mineralization; Osteopontin; Runx2; Type 1 collagen

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; CALCIUM; CELL PROTEIN; COLLAGEN TYPE 1; DIOSGENIN; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; CALCIFICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; MINERALIZATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; BONE MATRIX; CALCIFICATION, PHYSIOLOGIC; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DIOSGENIN; EXTRACELLULAR MATRIX; MICE; OSTEOBLASTS; OSTEOGENESIS; OSTEOPONTIN;

DIOSCOREA; DIOSCOREA VILLOSA; MURINAE;

EID: 80052596093     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.09.003     Document Type: Article

References (30)

1. Wang D., Christensen K., Chawla K., Xioa G., Krebsbach P.H., Franceschi R.T. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 1999, 14:893-903.
2. Katagiri T., Nakahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002, 8:147-159.
3. Lee S.U., Shin H.K., Min Y.K., Kim S.H. Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression. Int Immunopharmacol 2008, 8:741-747.
4. Rodan G., Martin J.T. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.
5. Raju J., Bird R.P. Diosgenin, a naturally occurring furostanol saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett 2007, 255:194-204.
6. Chiang C.T., Way T.D., Tsai S.J., Kin J.K. Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Lett 2007, 581:5735-5742.
7. Cailleteau C., Battu S., Jayat-Vignoles C., Beneytout J.L. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells. Anal Biochem 2008, 380:26-34.
8. Moalic S., Liagre B., Corbiere C., Bianchi A., Dauca M., Bordji K., et al. A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett 2001, 506:225-230.
9. Leger D.Y., Liagre B., Cardot P.J.P., Beneytout J.L., Battu S. Diosgenin dose-dependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring. Anal Biochem 2004, 335:267-278.
10. Corbiare C., Liagre B., Bianchi A., Bordji K., Dauca M., Netter P., et al. Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin, and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol 2003, 22(4):899-905.
11. Cayen M.N., Dvornik D. Effect of diosgenin on lipid metabolism in rats. J Lipid Res 1979, 20:163-174.
12. Higdon K., Scott A., Tucci M., Benghuzzi H., Tsao A., Puckett A., et al. The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomed Sci Instrum 2001, 37:281-286.
13. Yen M.L., Su J.L., Chien C.L., Tseng K.W., Yang C.Y., Chen W.F., et al. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Mol Pharmacol 2005, 68:1061-1073.
14. Putnam S., Scutt A., Bicknell K., Priestly C., Williamson E. Natural products as an alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res 2006, 21:99-112.
15. Kim M.H., Shim K.S., Lee S.U., Kim Y.S., Min Y.K., Kim S.H. Stimulatory effect of undecylenic acid on mouse osteoblast differentiation. Phytother Res 2009, 24:559-564.
16. Gutierrez G., Mundy B., Rossini G., Garrett I.R., Chen S., Mundy G. Red yeast stimulates bone formation in rats. Nutri Res 2006, 26:124-129.
17. Sethi G., Aggarwal B. Mending the bones with natural products. Chem Biol 2007, 14:738-740.
18. Shen C.L., Yeh J.K., Cao J., Wang J.S. Green tea and bone metabolism. Nutri Res 2009, 29:437-456.
19. Maeda T., Matsunuma A., Kawane T., Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001, 280:874-877.
20. Hsieh T.P., Sheu S.Y., Sun J.S., Chen M.H., Liu M.H. Icariin isolated from Epimedium pubescens regulates osteoblast anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine 2010, 17:414-423.
21. Tang C.H., Huang T.H., Chang C.S., Fu W.M., Yang R.S. Water solution of onion crude powder inhibits RANKL-induced osteoclastogenesis through ERK, p38 and NF-κB pathways. Osteoporos Int 2009, 20:93-103.
22. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodelling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 56:623-628.
23. Lian J., Stein G. Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 1992, 3:269-305.
24. Franceschi R.T., Iyer B.S., Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994, 9:843-854.
25. Lynch M., Stein J., Stein G., Lian J. The influence of Type 1 collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 1995, 216:35-45.
26. Wu X., Itoh N., Taniguchi T., Hirano J., Nakanishi T., Tanaka K. Stimulation of differentiation in sodium-dependent vitamin C transporter 2 overexpressing MC3T3-E1 osteoblasts. Biochem Biophys Res Commun 2004, 317:1159-1164.
27. Balcerzak M, Hamade E, Zhang L, Pikula S, Azzar G, Radisson J, Bandorowicz-Pikula J, Buchet R The roles of annexins and alkaline phosphates in mineralization process. Acta Biochim Pol 2003, 50:1019-1038.
28. Nakano Y., Addison W., Kaartinen M.T. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures. Bone 2007, 41:549-561.
29. Murshed M., Harmey D., Millan J.L., McKee M.D., Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 2005, 19:1093-1104.
30. Ducy P., Starbuck M., Priemel M., Shen J., Pinero R., Geoffroy V., et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999, 13:1025-1036.